Validity of cardiovascular risk prediction models in kidney transplant recipients

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Mansell, Holly ^a   Stewart, Samuel Alan ^b   Shoker, Ahmed ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CINAHL; COHORT ANALYSIS; DATA EXTRACTION; DIABETES MELLITUS; EMBASE; FRAMINGHAM RISK SCORE; GRAFT RECIPIENT; HUMAN; INFORMATION RETRIEVAL; ISCHEMIC HEART DISEASE; KIDNEY GRAFT; MEDLINE; POPULATION AND POPULATION RELATED PHENOMENA; PROGNOSIS; REVIEW; RISK ASSESSMENT; SMOKING; STUDY DESIGN; SYSTEMATIC REVIEW; VALIDITY; CARDIOVASCULAR DISEASE; COMORBIDITY; EPIDEMIOLOGY; EVALUATION STUDY; INCIDENCE; KIDNEY TRANSPLANTATION; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; VALIDATION STUDY;

CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84900009130     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/750579     Document Type: Review

References (53)

1. U S Renal Data System,. USRDS, 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2012, http://www.usrds.org/atlas.aspx
2. Arend S. M., Mallat M. J. K., Westendorp R. J. W., Van Der Woude F. J., Van Es L. A., Patient survival after renal transplantation; more than 25 years follow-up. Nephrology Dialysis Transplantation 1997 12 8 1672 1679 2-s2.0-0030845537 10.1093/ndt/12.8.1672
3. Ojo A. O., Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006 82 5 603 611 2-s2.0-33748778507 10.1097/01.tp.0000235527.81917.fe
4. Foley R. N., Parfrey P. S., Sarnak M. J., Epidemiology of cardiovascular disease in chronic renal disease. Journal of the American Society of Nephrology 1998 9 12 S16 S23 2-s2.0-0032229826
5. Gill J. S., Cardiovascular disease in transplant recipients: current and future treatment strategies. Clinical Journal of the American Society of Nephrology 2008 3 2 S29 S37 2-s2.0-41749097053 10.2215/CJN.02690707
6. Shirali A. C., Bia M. J., Management of cardiovascular disease in renal transplant recipients. Clinical Journal of the American Society of Nephrology 2008 3 2 491 504 2-s2.0-42549166926 10.2215/CJN.05081107
7. Ducloux D., Motte G., Challier B., Gibey R., Chalopin J.-M., Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. Journal of the American Society of Nephrology 2000 11 1 134 137 2-s2.0-0033980289
8. Winkelmayer W. C., Lorenz M., Kramar R., Födinger M., Hörl W. H., Sunder-Plassmann G., C-reactive protein and body mass index independently predict mortality in kidney transplant recipients. The American Journal of Transplantation 2004 4 7 1148 1154 2-s2.0-3042823812 10.1111/j.1600-6143.2004. 00477.x
9. Wilson P. W. F., D'Agostino R. B., Levy D., Belanger A. M., Silbershatz H., Kannel W. B., Prediction of coronary heart disease using risk factor categories. Circulation 1998 97 18 1837 1847 2-s2.0-0032510639
10. Ducloux D., Kazory A., Chalopin J.-M., Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney International 2004 66 1 441 447 2-s2.0-3042845600 10.1111/j.1523-1755.2004.00751.x
11. Silver S. A., Huang M., Nash M. M., Prasad G. V. R., Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients. Transplantation 2011 92 2 183 189 2-s2.0-79960290458 10.1097/TP.0b013e31821f303f
12. Blum C. B., Effects of sirolimus on lipids in renal allograft recipients: an analysis using the Framingham risk model. The American Journal of Transplantation 2002 2 6 551 559 2-s2.0-0036664390 10.1034/j.1600-6143.2002. 20610.x
13. Rogers C. C., Alloway R. R., Boardman R., Trofe J., Hanaway M. J., Alexander J. W., Roy-Chaudhury P., Buell J. F., Thomas M., Susskind B., Woodle E. S., Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation. Transplantation Proceedings 2005 37 2 812 813 2-s2.0-17844366107 10.1016/j.transproceed.2005.01.060
14. Marcén R., Chahin J., Alarcón A., Bravo J., Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a Prospective Study. Transplantation Proceedings 2006 38 8 2427 2430 2-s2.0-33750605108 10.1016/j.transproceed.2006.08.070
15. Rike A. H., Mogilishetty G., Alloway R. R., Succop P., Roy-chaudhury P., Cardi M., Kaiser T. E., Thomas M., Woodle E. S., Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clinical Transplantation 2008 22 2 229 235 2-s2.0-41049091005 10.1111/j.1399-0012.2007. 00779.x
16. Ridker P. M., Buring J. E., Rifai N., Cook N. R., Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. Journal of the American Medical Association 2007 297 6 611 619 2-s2.0-33846996345 10.1001/jama.297.6.611
17. Conroy R. M., Pyörälä K., Fitzgerald A. P., Sans S., Menotti A., De Backer G., De Bacquer D., Ducimetière P., Jousilahti P., Keil U., Njølstad I., Oganov R. G., Thomsen T., Tunstall-Pedoe H., Tverdal A., Wedel H., Whincup P., Witheimsen L., Graham I. M., Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 2003 24 11 987 1003 2-s2.0-0038579421 10.1016/S0195-668X(03)00114-3
18. Assmann G., Cullen P., Schulte H., Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 2002 105 3 310 315 2-s2.0-0037154285 10.1161/hc0302.102575
19. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., May M., Brindle P., Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. British Medical Journal 2007 335 7611 136 141 2-s2.0-34447619161 10.1136/bmj.39261.471806.55
20. Collins G. S., Altman D. G., An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. British Medical Journal 2010 340 c2442 2-s2.0-77952514407 10.1136/bmj.c2442
21. Soveri I., Holme I., Holdaas H., Budde K., Jardine A. G., Fellstrom B., A cardiovascular risk calculator for renal transplant recipients. Transplantation 2012 94 57 62
22. Tangri N., Kitsios G. D., Inker L. A., Risk prediction models for patients with chronic kidney disease: a systematic review. Annals of Internal Medicine 2013 158 596 603
23. Hayden J. A., Côté P., Bombardier C., Evaluation of the quality of prognosis studies in systematic reviews. Annals of Internal Medicine 2006 144 6 427 437 2-s2.0-33645642434
24. Hayden J. A., van der Windt D. A., Cartwright J. L., Côté P., Bombardier C., Assessing bias in studies of prognostic factors. Annals of Internal Medicine 2013 158 280 286
25. Kasiske B. L., Chakkera H. A., Roel J., Explained and unexplained ischemic heart disease risk after renal transplantation. Journal of the American Society of Nephrology 2000 11 9 1735 1743 2-s2.0-0033843762
26. Bastuji-Garin S., Deverly A., Moyse D., Castaigne A., Mancia G., De Leeuw P. W., Ruilope L. M., Rosenthal T., Chatellier G., The Framingham prediction rule is not valid in a European population of treated hypertensive patients. Journal of Hypertension 2002 20 10 1973 1980 2-s2.0-0036806860 10.1097/00004872-200210000-00016
27. Vergouwe Y., Steyerberg E. W., Eijkemans M. J. C., Habbema J. D. F., Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. Journal of Clinical Epidemiology 2005 58 5 475 483 2-s2.0-17444420853 10.1016/j.jclinepi.2004.06.017
28. Kiberd B., Panek R., Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited. Clinical Journal of the American Society of Nephrology 2008 3 3 822 828 2-s2.0-44649087813 10.2215/CJN.00030108
29. D'Agostino R. B. Sr., Grundy S., Sullivan L. M., Wilson P., Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Journal of the American Medical Association 2001 286 2 180 187 2-s2.0-0034945516
30. Khanna R., Kapoor A., Kumar S., Tewari S., Garg N., Goel P. K., Metabolic syndrome & Framingham Risk Score: observations from a coronary angiographic study in Indian patients. Indian Journal of Medical Research 2013 137 295 301
31. Cappuccio F. P., Oakeshott P., Strazzullo P., Kerry S. M., Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study. British Medical Journal 2002 325 7375 1271 1274 2-s2.0-0037202706
32. Statistics Canada, 2011 National Household Survey. Statistics Canada Catalogue no. 00-012-X2011016, http://www12.statcan.gc.ca/nhs-enm/2011/dp-pd/dt- td/Dir-eng.cfm
33. Israni A. K., Snyder J. J., Skeans M. A., Peng Y., MacLean J. R., Weinhandl E. D., Kasiske B. L., Predicting coronary heart disease after kidney transplantation: patient outcomes in renal transplantation (PORT) Study. The American Journal of Transplantation 2010 10 2 338 353 2-s2.0-75149181301 10.1111/j.1600-6143.2009.02949.x
34. Fellström B., Jardine A. G., Soveri I., Cole E., Neumayer H.-H., Maes B., Gimpelewicz C., Holdaas H., Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. The American Journal of Transplantation 2005 5 8 1986 1991 2-s2.0-22844450094 10.1111/j.1600-6143.2005.00983.x
35. Soveri I., Snyder J., Holdaas H., The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials. Transplantation 2013 95 142 147
36. Altman D. G., Royston P., What do we mean by validating a prognostic model? Statistics in Medicine 2000 19 453 473
37. Justice A. C., Covinsky K. E., Berlin J. A., Assessing the generalizability of prognostic information. Annals of Internal Medicine 1999 130 6 515 524 2-s2.0-0033574245
38. Toll D. B., Janssen K. J. M., Vergouwe Y., Moons K. G. M., Validation, updating and impact of clinical prediction rules: a review. Journal of Clinical Epidemiology 2008 61 11 1085 1094 2-s2.0-52949100612 10.1016/j.jclinepi.2008.04. 008
39. Rigatto C., Parfrey P., Foley R., Negrijn C., Tribula C., Jeffery J., Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. Journal of the American Society of Nephrology 2002 13 4 1084 1090 2-s2.0-0036209854
40. Ponticelli C., Villa M., Cesana B., Montagnino G., Tarantino A., Risk factors for late kidney allograft failure. Kidney International 2002 62 5 1848 1854 2-s2.0-0036406195
41. Kasiske B. L., Guijarro C., Massy Z. A., Wiederkehr M. R., Ma J. Z., Cardiovascular disease after renal transplantation. Journal of the American Society of Nephrology 1996 7 1 158 165 2-s2.0-0030042245
42. Krämer B. K., Zülke C., Kammerl M. C., Schmidt C., Hengstenberg C., Fischereder M., Marienhagen J., Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. The American Journal of Transplantation 2003 3 8 982 987 2-s2.0-0043267635 10.1034/j.1600-6143.2003.00156.x
43. Meier-Kriesche H.-U., Steffen B. J., Hochberg A. M., Gordon R. D., Liebman M. N., Morris J. A., Kaplan B., Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration. Transplantation 2003 75 8 1341 1346 2-s2.0-0242417526 10.1097/01.TP.0000062833.14843.4B
44. Ducloux D., Motte G., Massy Z. A., Hyperhomocyst(e)inemia as a risk factor after renal transplantation. Annals of Transplantation 2001 6 4 40 42 2-s2.0-0035749244
45. Weiner D. E., Tighiouart H., Elsayed E. F., Griffith J. L., Salem D. N., Levey A. S., Sarnak M. J., The Framingham predictive instrument in chronic kidney disease. Journal of the American College of Cardiology 2007 50 3 217 224 2-s2.0-34447105854 10.1016/j.jacc.2007.03.037
46. Meier-Kriesche H.-U., Baliga R., Kaplan B., Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003 75 8 1291 1295 2-s2.0-0037469059 10.1097/01.TP.0000061602. 03327.E2
47. Weiner D. E., Carpenter M. A., Levey A. S., Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial. The American Journal of Transplantation 2012 12 2437 2445
48. Janssen K. J. M., Moons K. G. M., Kalkman C. J., Grobbee D. E., Vergouwe Y., Updating methods improved the performance of a clinical prediction model in new patients. Journal of Clinical Epidemiology 2008 61 1 76 86 2-s2.0-36849089158 10.1016/j.jclinepi.2007.04.018
49. Pita-Fernandez S., Pertega-Diaz S., Valdes-Canedo F., Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol. BMC Cardiovascular Disorders 2011 11 article 2
50. Reilly B. M., Evans A. T., Translating clinical research into clinical practice: impact of using prediction rules to make decisions. Annals of Internal Medicine 2006 144 3 201 209 2-s2.0-33644855006
51. Moons K. G. M., Altman D. G., Vergouwe Y., Royston P., Prognosis and prognostic research: application and impact of prognostic models in clinical practice. British Medical Journal 2009 338 b606 2-s2.0-67650011095 10.1136/bmj.b606
52. Gupta A., Wroe C., Mi H., Asher J., Gok M. A., Shenton B. K., Ward M., Talbot D., Cardiovascular risk assessment scoring system for the determination of cardiovascular mortality in renal transplant patients. Transplantation Proceedings 2005 37 8 3290 3291 2-s2.0-27844589960 10.1016/j.transproceed.2005. 09.070
53. de Pádua Netto M. V., Bonfim T. C., Costa E. N., de Lima H. V., Netto L. C., Cardiovascular risk estimated in renal transplant recipients with the Framingham score. Transplantation Proceedings 2012 44 2337 2340